ENTITY
Boston Scientific

Boston Scientific (BSX US)

106
Analysis
Health Care • United States
Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.
more
bullish•Broncus
•07 Sep 2021 23:14

Broncus IPO: Every Breath They Take

Broncus is pre-marketing an HKEx IPO to raise $300m. The core products' differentiation in terms of technology and target indications increases the...

Logo
393 Views
Share
bullish•MicroPort CardioFlow
•21 Jan 2021 23:41

MicroPort CardioFlow: PHIP Updates and More on TMV

MicroPort CardioFlow plans an HKEX listing. This Insight discusses updated disclosures in its PHIP filing; developments in the TAVR market; the...

Share
bullish•Alibaba Health
•18 Dec 2020 20:56

China Healthcare: Macro Themes

This Insight summarizes the takeaways from a recent China healthcare industry conference.  There is much talk of pressures on the industry, but...

Share
bullish•Siemens Healthineers
•05 Aug 2020 20:06

Varian-Siemens Deal: DAX Promotion on the Cards for the Acquirer

This is the largest healthcare sector M&A Deal announced so far in 2020. Earlier this year, in March, Thermo Fisher Scientific Inc (TMO US)...

Share
bullish•Olympus Corp
•27 Nov 2017 09:04

Olympus (7733)--Why the Offering Is a Long-Term Buying Opportunity

Olympus announced a second-party share offering after market close on Friday, November 24th. This $406m offering (based on Friday's closing price)...

Logo
372 Views
Share
x